Recombinant proteins designed for improved therapeutic profiles that target unmet medical needs
Discovery &
Preclinical
Preclinical
Phase I
Phase II
Phase III
Marketing
Application
Application
Pipeline
subtitle
© 2024 Protalix Biotherapeutics Inc.
You are about to leave the Protalix BioTherapeutics, Inc. website.
Links to other websites are provided for general informational purposes only Protalix BioTherapeutics, Inc.
assumes no responsibility for information you may encounter on websites that are not owned or operated by Protalix BioTherapeutics, Inc.